Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Linden

Showing results (381-390 of 409) with videos related to

Pageof 41
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)P Sharma, W E Barlow, A K Godwin, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 26, 1999
Cross-cultural comparison of depressive symptoms in Europe does not support stereotypes of ageingJ R Copeland, A T Beekman, M E Dewey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 2, 2023
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-<sup>18</sup>F-Fluoro-17β-FluoroestradiolGary A Ulaner, David A Mankoff, Amy S Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptakeLisa K Dunnwald, Robert K Doot, Jennifer M Specht, et al.
The Breast Journal|June 28, 2026
Real-World Practice Patterns in Diagnosis and First-Line Treatment in Metastatic Breast CancerPoorni M Manohar, Veena Shankaran, Nancy E Davidson, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Clinical Trial Design and Development Work Group Within the Quantitative Imaging NetworkElla F Jones, John M Buatti, Hui-Kuo Shu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancerJennifer M Specht, Brenda F Kurland, Susan K Montgomery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2008
Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancerLisa K Dunnwald, Julie R Gralow, Georgiana K Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancerHannah M Linden, Svetlana A Stekhova, Jeanne M Link, et al.
Medical Physics|July 3, 2015
Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studiesJason M Williams, Sudheer D Rani, Xia Li, et al.
Pageof 41

Showing results (381-390 of 409) with videos related to

Sort By:
Pageof 41
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)P Sharma, W E Barlow, A K Godwin, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 26, 1999
Cross-cultural comparison of depressive symptoms in Europe does not support stereotypes of ageingJ R Copeland, A T Beekman, M E Dewey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 2, 2023
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-<sup>18</sup>F-Fluoro-17β-FluoroestradiolGary A Ulaner, David A Mankoff, Amy S Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptakeLisa K Dunnwald, Robert K Doot, Jennifer M Specht, et al.
The Breast Journal|June 28, 2026
Real-World Practice Patterns in Diagnosis and First-Line Treatment in Metastatic Breast CancerPoorni M Manohar, Veena Shankaran, Nancy E Davidson, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Clinical Trial Design and Development Work Group Within the Quantitative Imaging NetworkElla F Jones, John M Buatti, Hui-Kuo Shu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancerJennifer M Specht, Brenda F Kurland, Susan K Montgomery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2008
Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancerLisa K Dunnwald, Julie R Gralow, Georgiana K Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancerHannah M Linden, Svetlana A Stekhova, Jeanne M Link, et al.
Medical Physics|July 3, 2015
Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studiesJason M Williams, Sudheer D Rani, Xia Li, et al.
Pageof 41